Sana Biotechnology SANA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's operating income?
- Sana Biotechnology (SANA) reported operating income of -$48.61M in Q1 2026.
- How has Sana Biotechnology's operating income changed year-over-year?
- Sana Biotechnology's operating income increased by 4.0% year-over-year, from -$50.63M to -$48.61M.
- What is the long-term trend for Sana Biotechnology's operating income?
- Over 4 years (2021 to 2025), Sana Biotechnology's operating income has grown at a -8.5% compound annual growth rate (CAGR), from -$356.91M to -$250.32M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.